MicMac, As you say, excellent and "fresh" artic
Post# of 148158
As you say, excellent and "fresh" article. It reminds us why we are invested in CYDY. From the CONCLUSIONS section:
Quote:
CCR5 is central to HIV pathogenesis. Targeting this receptor was successfully used as an antiretroviral therapy and could be successfully expanded to either other infections or to medical areas which are unrelated to infectious diseases.
We all know this, however, as far as I am concerned what matters is the science behind Leronlimab.
It will prevail.
The missing zeroes (several of them) on my bank account should be just just temporary. Why ???
Well, just read this article (and the other 100's conveying the same message: LL works).
What can stop us ?? Management, let's hope we have good leaders to take us to the goal.
Overoptimistic??, As I always say to myself: If solid science does not work as an investment guideline in bio-tech, what will ??